Fulgent Genetics, Inc. FLGT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $71.14M-3.2% | $83.34M+9.3% | $84.07M+17.2% | $81.8M+15.2% | $73.46M+13.9% | ||
| $49.65M+10.0% | $50.75M+14.4% | $48.56M+8.0% | $47.37M+6.4% | $45.12M+6.5% | ||
| $21.49M-24.2% | $32.58M+2.3% | $35.51M+32.7% | $34.44M+30.0% | $28.35M+28.2% | ||
| 30.2%-8.4pp | 39.1%-2.7pp | 42.2%+4.9pp | 42.1%+4.8pp | 38.6%+4.3pp | ||
| $14.18M+14.4% | $14.17M+17.0% | $13.86M+17.6% | $13.48M0.0% | $12.4M+8.4% | ||
| $12.22M+44.4% | $10.98M+15.1% | $11.64M+27.6% | $12.29M+42.9% | $8.47M-5.8% | ||
| $27.68M+9.5% | $41.65M+71.1% | $23.34M+11.4% | $26.39M+23.8% | $25.29M+17.7% | ||
| $2.03M+2.1% | $2.03M+1.7% | $2.03M+1.6% | $1.99M0.0% | $1.99M0.0% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $56.11M+16.6% | $68.82M+43.4% | $50.86M+16.0% | $54.15M+19.3% | $48.14M+9.7% | ||
| $56.11M+16.6% | $68.82M+43.4% | $50.86M+16.0% | $54.15M+19.3% | $48.14M+9.7% | ||
| -$34.62M-74.9% | -$36.24M-125% | -$15.35M+10.1% | -$19.71M-4.3% | -$19.8M+9.2% | ||
| -48.7%-21.7pp | -43.5%-22.3pp | -18.3%+5.5pp | -24.1%+2.5pp | -26.9%+6.9pp | ||
| $17K+21.4% | $16K— | $28K+100% | $17K-32.0% | $14K+106% | ||
| $8.65M+7.9% | $6.94M-14.6% | $7.87M-2.7% | $8.09M+5.0% | $8.02M+8.6% | ||
| $8.64M+7.1% | $6.96M-13.9% | $7.84M+640% | -$1.81M-123% | $8.07M+5.9% | ||
| -$25.98M-122% | -$29.27M-264% | -$7.51M+59.5% | -$21.52M-91.9% | -$11.72M+17.3% | ||
| -$704K-500% | -$5.62M-203% | -$683K+82.2% | -$2.26M-6.5% | $176K+154% | ||
| -$24.83M-115% | -$23.42M-298% | -$6.61M+54.9% | -$18.96M-118% | -$11.53M+14.4% | ||
| -34.9%-19.2pp | -28.1%-20.4pp | -7.9%+12.6pp | -23.2%-10.9pp | -15.7%+5.2pp | ||
| -$0.80-116% | -$0.76-300% | -$0.21+56.3% | -$0.62-114% | -$0.37+17.8% | ||
| -$0.80-116% | -$0.76-300% | -$0.21+56.3% | -$0.62-114% | -$0.37+17.8% | ||
| 30.9M+0.2% | 30.8M+1.8% | 30.7M+1.1% | 30.5M+1.5% | 30.8M+3.6% | ||
| 30.9M+0.2% | 30.8M+1.8% | 30.7M+1.1% | 30.5M+1.5% | 30.8M+3.6% | ||
| -$0.8-116% | -$0.76-300% | -$0.21+56.3% | -$0.62-114% | -$0.37+17.8% | ||
| -$0.8-116% | -$0.76-300% | -$0.21+56.3% | -$0.62-114% | -$0.37+17.8% | ||
| $2.03M+2.1% | $2.03M+1.7% | $2.03M+1.6% | $1.99M0.0% | $1.99M0.0% | ||
| -$1.12M-742% | -$104K+71.4% | -$864K+63.4% | -$113K+75.3% | -$133K+76.1% | ||
| $88K-35.3% | $88K-35.3% | $88K-34.8% | $87K-37.0% | $136K+0.7% | ||
| $9K+350% | —— | $1K+102% | —— | $2K+101% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$408K+38.0% | $924K— | -$102K-104% | $386K-79.0% | -$658K-169% | ||
| -$16.43M-463% | $15.38M+15.4% | —— | $8.26M+187% | $4.52M+405% | ||
| -$2.12M+71.6% | $12.33M— | -$1.13M+38.0% | $5.2M— | -$7.49M-70.7% | ||
| -$2.79M-247% | -$1.82M-135% | $1.37M+0.7% | —— | -$804K-3,450% | ||
| -$44.83M-301% | -$534K-63.3% | -$445K+21.5% | -$2.64M-130% | -$11.17M-298% | ||
| $10.94M-60.6% | $11.15M+141% | $19.08M— | $53.4M— | $27.73M+159% | ||
| $7.1M+260% | -$78.14M-412% | —— | -$30.17M-804% | -$4.43M-161% | ||
| -$1K+95.2% | —— | -$1K+94.7% | -$12K— | -$21K-275% | ||
| $10K-85.3% | $44K+529% | -$5K-101% | $46K+318% | $68K+856% | ||
| $40.08M+362% | —— | —— | $2.21M— | $8.68M+3,757% | ||
| $4.2M+123% | $447K+84.7% | $357K-17.2% | $345K-36.6% | $1.89M+12.2% | ||
| $55.57M— | —— | —— | —— | $0— | ||
| $5.2M+10.3% | $4.98M+31.8% | $6.05M-69.0% | $6.83M-47.3% | $4.72M+16.3% | ||
| $8K+300% | —— | $3K-92.1% | —— | $2K-99.2% | ||
| $9K— | —— | —— | —— | $0-100% | ||
| $1.19M-42.7% | $1.85M— | $1.13M— | $2.59M+256% | $2.08M+183% | ||
| $71.14M-3.2% | $83.34M+9.3% | $84.07M+17.2% | $81.8M+15.2% | $73.46M+13.9% | ||
| $9.89M-6.3% | $9.28M-10.9% | $9.72M-11.0% | $10.04M-13.7% | $10.55M-8.4% | ||
| -$34.62M-74.9% | -$36.24M-125% | -$15.35M+10.1% | -$19.71M-4.3% | -$19.8M+9.2% | ||
| -$28.62M-106% | -$30.13M-203% | -$9.31M+16.6% | -$13.66M-7.1% | -$13.88M+8.3% | ||
| -$28.62M-106% | -$30.13M-203% | -$9.31M+16.6% | -$13.66M-7.1% | -$13.88M+8.3% | ||
| -40.2%-21.3pp | -36.2%-23.1pp | -11.1%+4.5pp | -16.7%+1.3pp | -18.9%+4.6pp | ||
| -$34.62M-74.9% | -$36.24M-125% | -$15.35M+10.1% | -$19.71M-4.3% | -$19.8M+9.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Fulgent Genetics, Inc.'s revenue?
- Fulgent Genetics, Inc. (FLGT) generated $320.3M in revenue over the trailing twelve months, up 9.5% year over year.
- Is Fulgent Genetics, Inc. profitable?
- Fulgent Genetics, Inc. is not currently profitable: it reported a net loss of $73.8M over the trailing twelve months, a -23.0% net margin.
- What are Fulgent Genetics, Inc.'s profit margins?
- Gross margin is 38.7% and operating margin is -33.1%, with a -23.0% net margin.
- What is Fulgent Genetics, Inc.'s earnings per share?
- Fulgent Genetics, Inc.'s diluted EPS over the trailing twelve months is $-2.39.
- Where does Fulgent Genetics, Inc.'s income statement data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
